Table 1.
Patients n= 12 | ||
---|---|---|
Gender | male | 11 (92 %) |
female | 1 (8 %) | |
Age | ≤60 | 2 (17 %) |
61-75 | 10 (83 %) | |
≥76 | 0 (0 %) | |
LV-function | normal | 12 (100 %) |
moderate-to-serve dysfunction | 0 (0 %) | |
Pharmacological | ACE-inhibitor | 7 (58 %) |
treatment | ß-blocker | 7 (58 %) |
Ca2+ -antagonist | 3 (25 %) | |
digitoxin | 1 (8 %) | |
loop-diuretic | 6 (50 %) | |
K+-sparing diuretic | 3 (25 %) | |
thiazide-diuretic | 2 (17 %) | |
statin | 6 (50 %) | |
glyceryl trinitrate | 1 (8 %) | |
Cardiosurgical procedure | coronary artery bypass | 8 (67 %) |
aortic valve replacement | 3 (25 %) | |
mitral valve replacement or repair | 1 (8 %) | |
thoracic aneurysm repair | 1 (8 %) | |
left ventricular aneurysmectomy | 1 (8 %) |